These findings are in line with data from our recent study in muscle‐invasive urothelial carcinomas providing an example where a high expression of TIM3, PD‐1, and CTLA‐4 on immune cell subpopulations was linked to a favorable outcome in an inflamed immune phenotype [26]. This evidence concerns the gene CTLA4 and urothelial carcinoma.